Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
2
Mins
1 Dec 2016
Experience of the Management of Decompensated Hepatitis C Virus in Cirrhotic Patients with Low-Dose Sofosbuvir and Ribavirin Combined with Daclatasvir
The limited treatment varieties for patients with decompensated cirrhosis due to the hepatitis C virus (HCV) remain a challenge. Read more
6
Mins
1 Dec 2016
Preventing Collateral Damage in the Inflammatory Bowel Disease Patient: Using Disease Assessment and Prognostic Factors to Optimise Clinical Outcomes
Inflammatory bowel diseases (IBDs) are chronic disabling conditions. Despite the benefits of anti-tumour necrosis factor-α agents in improving quality…
2
Mins
1 Dec 2016
Associations of the TLR2 and TLR4 Alleles with Hepatitis C Virus Infection Within an Egyptian Population: A Multicentre Family-Based Study
The human toll-like receptor (TLR) family consists of 10 receptors that are critically important within innate immunity. TLRs recognise and respond to…
2
Mins
1 Dec 2016
Endoscopic Necrosectomy: Indications and Results
Peripancreatic fluid collections (PFC) frequently occur in the context of acute and chronic pancreatitis, and trauma. The majority of cases have…
9
Mins
1 Dec 2016
Introducing Biosimilars into Current Inflammatory Bowel Disease Treatment Algorithms
Biosimilars follow a rigorous regulatory approval pathway designed to collect and review the totality of evidence from non-clinical analytical…
2
Mins
1 Dec 2016
Surgical Transanal Resection of Early Rectal Tumours
Rates of early rectal cancer detection are on the increase due to screening programmes and wider public awareness. Most rectal cancer is treated by…
7
Mins
1 Dec 2016
Relevance of Patient-Reported Outcomes for the Management of Patients with Inflammatory Bowel Disease
Patient adherence is a major problem in the treatment of inflammatory bowel disease (IBD). Research has shown that improved patient adherence and…
9
Mins
1 Dec 2016
Crohn’s Disease: Supporting Patients in Their Pursuit of Disease Control
The objectives of this symposium were to describe the current unmet needs in the treatment and management of inflammatory bowel diseases (IBDs) in…
3
Mins
1 Dec 2016
Curative Options for Hepatitis B and D
The hepatitis B virus (HBV) is a small, partially double-stranded DNA virus that causes acute and chronic hepatitis in humans. About 240 million people…
8
Mins
1 Dec 2016
Editor’s Pick: “Should I Be Concerned with the Long-Term Use of Proton Pump Inhibitor Therapy?”
Proton pump inhibitors (PPI) are one of the most widely prescribed drugs worldwide. They are the mainstay for treatment of most gastric acid-related…
←
1
2
3
…
935
936
937
938
939
940
941
…
1,105
1,106
1,107
→
We’ve noticed you’re accessing
from
North/South America.
View
View